SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-23-025098
Filing Date
2023-07-20
Accepted
2023-07-20 16:25:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 673939
2 form424b5_001.jpg GRAPHIC 8169
  Complete submission text file 0001493152-23-025098.txt   686383
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252430 | Film No.: 231100136
SIC: 2834 Pharmaceutical Preparations